Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds BVXV.
No tracked institution reports a position in BVXV as of their last filing.
No one on the platform has traded BVXV yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 3 of the last 5 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-08-11 | $-0.91 | $1.11 | +222.0% |
| 2022-11-30 | $0.10 | $0.06 | -40.0% |
| 2022-08-25 | $-1.05 | $2.10 | +300.0% |
| 2022-06-01 | $-1.00 | $2.00 | +300.0% |
| 2022-03-28 | $-0.85 | $-2.70 | -217.6% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BVXVBiondVax Pharmaceuticals Ltd. | $1.36 | +0.74% | $5M | — |
| APTOAptose Biosciences Inc. | $1.71 | +100.00% | $4M | — |
| CYTOAltamira Therapeutics Ltd. | $0.30 | +100.00% | $1M | — |
| FRTXFresh Tracks Therapeutics, Inc. | $0.94 | -0.53% | $6M | — |
| GMDAGamida Cell Ltd. | $0.03 | +0.00% | $4M | — |
| HILSHillstream BioPharma, Inc. | $0.24 | +5.66% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
| NBRVFNabriva Therapeutics plc | $0.00 | +0.00% | $323 | — |